FULGENT GENETICS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
FULGENT GENETICS, INC. (FLGT) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$31.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2018-03-20
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-12-31 was $0.00.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-09-30 was $0.00.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-06-30 was -$14.00K.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-03-31 was -$17.00K.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2016 was -$31.00K.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2015 was -$3.00M.
- FULGENT GENETICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2014 was -$3.31M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | -$14.00K derived: sum of 3 quarters · filed 2018-03-20 | -$31.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$14.00K derived: sum of 2 quarters · filed 2017-11-13 | -$31.00K 10-Q · filed 2017-11-13 | -$947.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$31.00K 10-Q · filed 2017-08-14 | -$947.00K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$17.00K 10-Q · filed 2017-05-09 | -$933.00K derived: sum of 2 quarters · filed 2017-05-09 | ||
| 2015-12-31 | -$916.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$3.00M 10-K · filed 2017-03-17 | ||
| 2015-09-30 | -$2.08M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | -$3.31M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |